Open AccessCON (“The window is closed”): In patients with cirrhosis with ascites, the clinical risks of nonselective beta‐blocker outweigh the benefits and should NOT be prescribed
Author(s) -
Aday Ariel W.,
Rich Nicole E.,
Mufti Arjmand R.,
Tujios Shannan R.
Publication year - 2018
Publication title -
clinical liver disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 14
ISSN - 2046-2484
DOI - 10.1002/cld.699
Subject(s) - cirrhosis , ascites , therapeutic window , medicine , beta blocker , window (computing) , beta (programming language) , gastroenterology , pharmacology , computer science , heart failure , operating system , programming language
Watch a video presentation of this article